Skip to content
AI IntelligenceJun 29, 2026Secondary Market
Article

ELTP

Elite Pharmaceuticals filed an 8-K report covering results of operations and financial condition, along with Regulation FD disclosure, providing an important update for shareholders.

Data Cube AI EditorialSource: SEC EDGAR
01

Source Brief

Elite Pharmaceuticals filed an 8-K report covering results of operations and financial condition, along with Regulation FD disclosure, providing an important update for shareholders.